PT - JOURNAL ARTICLE AU - Strathdee, Steffanie A. AU - Abramovitz, Daniela AU - Harvey-Vera, Alicia AU - Vera, Carlos AU - Rangel, Gudelia AU - Artamonova, Irina AU - Chaillon, Antoine AU - Ignacio, Caroline AU - Calderon, Alheli AU - Martin, Natasha K. AU - Patterson, Thomas L. TI - Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region AID - 10.1101/2021.08.05.21261671 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.05.21261671 4099 - http://medrxiv.org/content/early/2021/08/07/2021.08.05.21261671.short 4100 - http://medrxiv.org/content/early/2021/08/07/2021.08.05.21261671.full AB - Background People who inject drugs may be at elevated SARS-CoV-2 risk due to their living conditions and/or exposures when seeking or using drugs. No study to date has reported upon risk factors for SARS-CoV-2 infection among people who inject drugs or sex workers.Methods and Findings Between October, 2020 and June, 2021, participants aged ≥18 years from San Diego, California, USA and Tijuana, Baja California, Mexico who injected drugs within the last month underwent interviews and testing for SARS-CoV-2 RNA and antibodies. Binomial regressions identified correlates of SARS-CoV-2 seropositivity. Of 386 participants, SARS-CoV-2 seroprevalence was 36.3% (95% CI: 31.5%-41.1%); 92.1% had detectable IgM antibodies. Only 37.5% had previously been tested. Seroprevalence did not differ by country of residence. None tested RNA-positive. Most (89.5%) reported engaging in ≥1 protective behavior [e.g., facemasks (73.5%), social distancing (46.5%), or increasing handwashing/sanitizers (22.8%)]. In a multivariate model controlling for sex, older age, and Hispanic/Latinx/Mexican ethnicity were independently associated with SARS-CoV-2 seropositivity, as was engaging in sex work (AdjRR: 1.63; 95% CI: 1.18-2.27) and having been incarcerated in the past six months (AdjRR: 1.49; 95% CI: 0.97-2.27). Presence of comorbidities and substance using behaviors were not associated with SARS-CoV-2 seropositivity.Conclusions This is the first study to show that sex work and incarceration were independently associated with SARS-CoV-2 infection. Despite engaging in protective measures, over one-third had evidence of infection, reinforcing the need for a coordinated binational response. Risk mitigation and vaccination is especially needed among older and Hispanic people who inject drugs and those with less agency to protect themselves, such as those who are sex workers or incarcerated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors gratefully acknowledge the La Frontera study team and participants in San Diego and Tijuana and the National Institute on Drug Abuse (R01DA049644-S1), staff at Genalyte and Fluxergy for assistance interpreting laboratory results, laboratory staff at the Center for AIDS Research (P30 AI036214), Dr Pamina Gorbach and grant U24DA044554 for assistance with survey measures, Dr. Davey Smith for helpful suggestions on the study design and Sharon Park for assistance with manuscript preparation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Protocols were approved by institutional review boards at the University of California San Diego and Xochicalco University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data used in this analysis is available after completion of the study in May 2022. Interested parties should contact Daniela Abramovitz at dabramovitz@health.ucsd.edu for more information on how to submit a data request.